Ferroni P, Formica V, Della-Morte D, Lucchetti J, Spila A, D'Alessandro R, Riondino S, Guadagni F, Roselli M. Prognostic value of glycated hemoglobin in colorectal cancer. World J Gastroenterol 2016; 22(45): 9984-9993 [PMID: 28018105 DOI: 10.3748/wjg.v22.i45.9984]
Corresponding Author of This Article
Patrizia Ferroni, MD, PhD, San Raffaele Roma Open University, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy. patrizia.ferroni@sanraffaele.it
Research Domain of This Article
Oncology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2016; 22(45): 9984-9993 Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9984
Table 1 Clinical characteristics of colorectal cancer patients - comparison between patients with or without impaired glucose tolerance or type 2 diabetes
Table 4 Cox proportional hazards survival regression analysis of the predictive value of clinical-pathological variables and glycemic indexes on progression-free and overall survival of colorectal cancer patients